Use of a Smartphone App Versus Motivational Interviewing to Increase Walking Distance and Weight Loss in Overweight/Obese Adults With Peripheral Artery Disease: Pilot Randomized Trial

Tracie Collins, Mugur Geana, Kathryn Overton, Mary Benton, Liuqiang Lu, Faarina Khan, Mason Rohleder, Jasjit Ahluwalia, Ken Resnicow, Yiliang Zhu, Tracie Collins, Mugur Geana, Kathryn Overton, Mary Benton, Liuqiang Lu, Faarina Khan, Mason Rohleder, Jasjit Ahluwalia, Ken Resnicow, Yiliang Zhu

Abstract

Background: Walking therapy improves functional outcomes in patients with peripheral artery disease (PAD). Less is known about the additive benefit of a dietary intervention.

Objective: Our objectives were to develop a smartphone app and, as a pilot, explore its potential efficacy as compared to motivational interviewing (MI) to increase walking distance and promote weight loss in overweight/obese adults with PAD.

Methods: We conducted a 3-month, 2-arm randomized pilot study at the University of Kansas. Inclusion criteria were BMI >27 kg/m2 and symptomatic PAD, defined by an ankle-brachial index <0.9. Patients were randomized into 2 groups: MI, delivered through in-person and telephone counseling, and app, a mobile smartphone app. Both interventions encouraged walking for exercise and healthy dietary habits (increasing fruits and vegetables and whole grains while reducing fat and sugary drinks). We assessed medical history at baseline. At baseline and 3 months, participants completed an assessment of 6-minute walking distance, weight, quality of life, exercise behaviors, and dietary habits. The primary outcome was 3-month change in walking distance. Secondary outcomes were changes in weight, quality of life, exercise behaviors, and dietary habits. We used a Wilcoxon rank-sum test to analyze the primary and secondary outcomes at 3 months within the MI and app groups and to compare the changes between the groups with adjustment for baseline.

Results: We randomized 29 participants with a mean age of 66.03 (SD 8.12) years; 25 participants completed the trial. At baseline, mean walking distance among completers was 260.40 (SD 94.32) meters and 326.15 (SD 69.28) meters for MI and app participants, respectively. At 3 months, the mean walking distance was 298.67 (SD 101.20) meters and 331.19 (SD 58.63) meters for MI and app participants, respectively (group difference P=.03, adjusting for baseline). Increase in walking distance at 3 months was 40.5 meters (95% CI 6.77 to 61.34; P=.02) in MI group. At baseline, mean body weight was 253.10 (SD 59.45) lbs and 225.13 (SD 58.93) lbs for MI and app participants, respectively. At 3 months, mean body weight was 242.14 (SD 58.54) lbs and 223.44 (SD 59.54) lbs for MI and app, respectively (group difference P=.006, adjusting for baseline). Pre-post study decrease in weight was 10.1 lbs (95% CI -17.9 to -3.0) and 2.3 lbs (95% CI -3.4 to -0.7) in MI and app group, respectively. Comparing baseline to 3 months, there were no statistically significant differences in quality of life, exercise behaviors, or dietary habits.

Conclusions: Our study demonstrates that MI can promote walking and weight loss in overweight/obese adults with PAD. The smartphone app showed a small weight loss but no statistically significant increase in walking distance. As this was a pilot study, future large-scale studies are needed to replicate the efficacy of MI to promote weight loss in overweight or obese adults with PAD.

Trial registration: ClinicalTrials.gov NCT03694652; https://ichgcp.net/clinical-trials-registry/NCT03694652.

Keywords: mobile health; motivational interviewing; peripheral artery disease; smartphone app.

Conflict of interest statement

Conflicts of Interest: None declared.

©Tracie Collins, Mugur Geana, Kathryn Overton, Mary Benton, Liuqiang Lu, Faarina Khan, Mason Rohleder, Jasjit Ahluwalia, Ken Resnicow, Yiliang Zhu. Originally published in JMIR Formative Research (https://formative.jmir.org), 03.02.2022.

Figures

Figure 1
Figure 1
PAD mobile app: components of walking and nutrition modules.
Figure 2
Figure 2
CONSORT flow diagram. ABI: ankle-brachial index; MI: motivational interviewing

References

    1. Shalan A, Abdulrahman A, Habli I, Tew G, Thompson A. YORwalK: desiging a smartphone exercise application for people with intermittent claudication. Stud Health Technol Inform. 2018;247:311–315.
    1. Heald CL, Fowkes FGR, Murray GD, Price JF, Ankle Brachial Index Collaboration Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis. 2006 Nov;189(1):61–69. doi: 10.1016/j.atherosclerosis.2006.03.011.S0021-9150(06)00139-0
    1. Ankle Brachial Index Collaboration. Fowkes FGR, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, deBacker G, Wautrecht J, Kornitzer M, Newman AB, Cushman M, Sutton-Tyrrell K, Fowkes FGR, Lee AJ, Price JF, d'Agostino RB, Murabito JM, Norman PE, Jamrozik K, Curb JD, Masaki KH, Rodríguez BL, Dekker JM, Bouter LM, Heine RJ, Nijpels G, Stehouwer CDA, Ferrucci L, McDermott MM, Stoffers HE, Hooi JD, Knottnerus JA, Ogren M, Hedblad B, Witteman JC, Breteler MMB, Hunink MGM, Hofman A, Criqui MH, Langer RD, Fronek A, Hiatt WR, Hamman R, Resnick HE, Guralnik J, McDermott MM. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008 Jul 09;300(2):197–208. doi: 10.1001/jama.300.2.197. 300/2/197
    1. McDermott MM, Guralnik JM, Tian L, Ferrucci L, Liu K, Liao Y, Criqui MH. Baseline functional performance predicts the rate of mobility loss in persons with peripheral arterial disease. J Am Coll Cardiol. 2007 Sep 04;50(10):974–982. doi: 10.1016/j.jacc.2007.05.030. S0735-1097(07)01935-3
    1. Collins TC, Petersen NJ, Suarez-Almazor M. Peripheral arterial disease symptom subtype and walking impairment. Vasc Med. 2005 Aug;10(3):177–183. doi: 10.1191/1358863x05vm615oa.
    1. Collins TC, Beyth RJ. Process of care and outcomes in peripheral arterial disease. Am J Med Sci. 2003 Mar;325(3):125–134. doi: 10.1097/00000441-200303000-00005.S0002-9629(15)34311-1
    1. Eason SL, Petersen NJ, Suarez-Almazor M, Davis B, Collins TC. Diabetes mellitus, smoking, and the risk for asymptomatic peripheral arterial disease: whom should we screen? J Am Board Fam Pract. 2005;18(5):355–361. doi: 10.3122/jabfm.18.5.355. 18/5/355
    1. Kim M, Kim C, Kim E, Choi M. Effectiveness of mobile health-based exercise interventions for patients with peripheral artery disease: systematic review and meta-analysis. JMIR Mhealth Uhealth. 2021 Feb 15;9(2):e24080. doi: 10.2196/24080. v9i2e24080
    1. Paldán K, Simanovski J, Ullrich G, Steinmetz M, Rammos C, Jánosi RA, Moebus S, Rassaf T, Lortz J. Feasibility and clinical relevance of a mobile intervention using TrackPAD to support supervised exercise therapy in patients with peripheral arterial disease: study protocol for a randomized controlled pilot trial. JMIR Res Protoc. 2019 Jun 26;8(6):e13651. doi: 10.2196/13651. v8i6e13651
    1. Campia U, Gerhard-Herman M, Piazza G, Goldhaber SZ. Peripheral artery disease: past, present, and future. Am J Med. 2019 Oct;132(10):1133–1141. doi: 10.1016/j.amjmed.2019.04.043.S0002-9343(19)30435-8
    1. Collins T, Ghidei W, Ahluwalia J. Benefits of walking therapy in patients with diabetes mellitus and peripheral arterial disease who are limited by leg pain or fatigue. J Gen Intern Med. 2011;26:S176.
    1. Gardner AW. Supervised exercise therapy provided by local physiotherapists improves walking distance in patients with claudication. Evid Based Med. 2011 Apr 21;16(2):43–44. doi: 10.1136/ebm1151.16/2/43
    1. McDermott MM, Liu K, Guralnik JM, Criqui MH, Spring B, Tian L, Domanchuk K, Ferrucci L, Lloyd-Jones D, Kibbe M, Tao H, Zhao L, Liao Y, Rejeski WJ. Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial. JAMA. 2013 Jul 03;310(1):57–65. doi: 10.1001/jama.2013.7231. 1707722
    1. Quirk F, Dickinson C, Baune B, Leicht A, Golledge J. Pilot trial of motivational interviewing in patients with peripheral artery disease. Int Angiol. 2012 Oct;31(5):468–473.R34122877
    1. Collins TC, Lu L, Ahluwalia JS, Nollen NL, Sirard J, Marcotte R, Post S, Zackula R. Efficacy of community-based exercise therapy among African American patients with peripheral artery disease: a randomized clinical trial. JAMA Netw Open. 2019 Feb 01;2(2):e187959. doi: 10.1001/jamanetworkopen.2018.7959. 2724773
    1. Miller WR. Motivational interviewing with problem drinkers. Behav Psychother. 2009 Jun 16;11(2):147–172. doi: 10.1017/s0141347300006583.
    1. Miller WR, Rollnick S. Meeting in the middle: motivational interviewing and self-determination theory. Int J Behav Nutr Phys Act. 2012;9:25. doi: 10.1186/1479-5868-9-25. 1479-5868-9-25
    1. Rollnick S, Allison J. Motivational interviewing. In: Heather N, Stockwell T, editors. The Essential Handbook of Treatment and Prevention of Alcohol Problems. West Sussex: John Wiley & Sons; 2004. pp. 105–116.
    1. Rollnick S, Miller WR. What is motivational interviewing? Behav Cogn Psychother. 2009 Jun 16;23(4):325–334. doi: 10.1017/S135246580001643X.
    1. Patrick K, Sallis JF, Long B, Calfas KJ, Wooten W, Heath G, Pratt M. A new tool for encouraging activity. Phys Sportsmed. 1994 Nov;22(11):45–55. doi: 10.1080/00913847.1994.11947706.
    1. Calfas KJ, Sallis JF, Oldenburg B, Ffrench M. Mediators of change in physical activity following an intervention in primary care: PACE. Prev Med. 1997;26(3):297–304. doi: 10.1006/pmed.1997.0141.S0091-7435(97)90141-9
    1. Collins TC, Petersen NJ, Suarez-Almazor M, Ashton CM. The prevalence of peripheral arterial disease in a racially diverse population. Arch Intern Med. 2003 Jun 23;163(12):1469–1474. doi: 10.1001/archinte.163.12.1469.163/12/1469
    1. Collins T, O'Malley K, Petersen N, Suarez-Almazor M. The Lifestyle and Clinical Survey: a pilot study to validate a medical history questionnaire. Fed Pract. 2005;22(5):25–46.
    1. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51(3):390–395. doi: 10.1037//0022-006x.51.3.390.
    1. Montgomery PS, Gardner AW. The clinical utility of a six-minute walk test in peripheral arterial occlusive disease patients. J Am Geriatr Soc. 1998 Jun;46(6):706–711. doi: 10.1111/j.1532-5415.1998.tb03804.x.
    1. Morgan MB, Crayford T, Murrin B, Fraser SC. Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia. J Vasc Surg. 2001 Apr;33(4):679–687. doi: 10.1067/mva.2001.112326. S0741-5214(01)73681-6
    1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, TASC II Working Group Inter-society consensus for the management of peripheral arterial disease (TASC II) J Vasc Surg. 2007 Jan;45 Suppl S:S5–S67. doi: 10.1016/j.jvs.2006.12.037. S0741-5214(06)02296-8
    1. Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract. 2001;4(6):256–262.
    1. Lorig K, Stewart A, Ritter P, Gonzalez V, Laurent D, Lynch J. Outcome Measures for Health Education and Other Health Care Interventions. Thousand Oaks: Sage Publications; 1996.
    1. Shannon J, Kristal AR, Curry SJ, Beresford SA. Application of a behavioral approach to measuring dietary change: the fat- and fiber-related diet behavior questionnaire. Cancer Epidemiol Biomarkers Prev. 1997 May;6(5):355–361.
    1. Thomas S, Reading J, Shephard RJ. Revision of the Physical Activity Readiness Questionnaire (PAR-Q) Can J Sport Sci. 1992 Dec;17(4):338–345.
    1. Criqui MH, Denenberg JO, Bird CE, Fronek A, Klauber MR, Langer RD. The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med. 1996;1(1):65–71. doi: 10.1177/1358863X9600100112.
    1. Cunningham MA, Swanson V, O'Carroll RE, O'Caroll RE, Holdsworth RJ. Randomized clinical trial of a brief psychological intervention to increase walking in patients with intermittent claudication. Br J Surg. 2012 Jan;99(1):49–56. doi: 10.1002/bjs.7714.
    1. Santarossa S, Kane D, Senn CY, Woodruff SJ. Exploring the role of in-person components for online health behavior change interventions: can a digital person-to-person component suffice? J Med Internet Res. 2018 Apr 11;20(4):e144. doi: 10.2196/jmir.8480. v20i4e144

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi